Rifamycin sodium

Rifamycin sodium primary indications include the treatment of tuberculosis, leprosy, and other bacterial infections resistant to more common antibiotics. In recent years, research has also explored its potential in treating conditions including traveler’s diarrhea and certain non-tuberculous mycobacterial infections. Its therapeutic use is listed as antibiotics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Rifamycin SV sodium, Rifamastene and Otofa. It is also listed for alternate use as: API Impurity, API Intermediate. Its PubChem CID is 23702994.

CAS No 14897-39-3
Molecular Formula C37H46NNaO12
Molecular Weight 719.7 g/mol
Synonyms sodium;(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-acetyloxy-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-27-olate

Frequently Asked Questions